N/A N=80 Quatera 700 vs. Centurion
Cataract
Primary: Central Corneal Thickness — 572.8; 565.6 microns
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=32 Phacoemulsification Versus Phacoemulsification With Micro-bypass Stent
Primary Angle-Closure Glaucoma · Primary Angle Closure Without Glaucoma Damage
Primary: Change in Intraocular Pressure Between Baseline and 1 Year — 15; 14.7 mmHg
Phase 3 N=60 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Capsulorhexis for Cataract Surgery
Cataract
Primary: Deviation From Intended Capsulotomy Diameter — 26.8; 339.1 μm
N/A N=390 Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts
Intumescent Cataract
Primary: Percentage of Capsular Tears (Anterior or Posterior) During Surgery — 5.3; 5.3 percentage of capsular tears
N/A N=106 Phaco Versus Small Incision Cataract Surgery (SICS) Health Economic Study
Cataract
Primary: Posterior Capsule Opacification Evaluation — 3; 28 participants
N/A N=100 Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery
Cataract
Primary: Total Lens Removal Time — 76.0; 80.1 seconds
N/A N=130 Cataract Surgery: Femto LDV Z8 Versus Conventional
Cataract
Primary: Effective Phaco Time (EPT) — 1.48; 2.3 EPT
Phase 3 N=178 Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification
Cataract
Primary: Visual Ability (VA) — 0.91; 0.87 units on a scale (LogMAR) — p=0.065
N/A N=100 Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Hoya iMics NY-60 vs Acrysof SN60WF
Capsule Opacification · Pseudophakia · Cataract
Primary: Posterior Capsule Opacification (PCO) — 3.0; 1.9 units on a scale (0-10)
N/A N=55 Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®
Cataract
Primary: Cumulative Dissipated Energy (CDE) — 0.213; 1.718 unitless — p=<0.0001
N/A N=120 Outcomes of 3 Incision-size-dependent Phacoemulsification Systems
Cataract
Primary: Central Cornea Endothelial Cell Loss — 11.78; 13.03; 12.05; 7.77 % of endothelial cell loss
N/A N=114 VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia
Myopia · Refractive Errors
Primary: Variability of the Refractive Predicatibility — -0.22 Diopters
Phase 2 N=148 Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification
Cataract · Phacoemulsification Cataract Surgery
Primary: Percentage of Cellularity in Anterior Chamber — 64.2; 64.3; 0; 0 Percentage of Cellularity — p=1.00
N/A N=15 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines
Cataract Surgery
Primary: Number of Eyes With Stable IOP — 16; 14 Eyes
N/A N=66 Physiologic Phacofluidics: Ghost Protocol
Cataract
Primary: Change in Early Post Operative Central Corneal Thickness — 623.9; 650.2 microns
Phase 3 N=122 One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction
Aphakia · Cataract
Primary: Visual Acuity — 108 Participants
Phase 1 N=357 Use of the VisuMax™ Femtosecond Laser
Myopia
Primary: Effectiveness- Predictability of Participant Refractive Outcomes — 291; 306 Participants
Phase 4 N=105 Sedation Methods During Cataract Surgery
Phacoemulsification · Cataract
Primary: Eye Mobility During Surgery (See Link to Study Protocol for Scale) — 1.39; 1.41; 1.31 units on a scale
N/A N=182 Comparison of Centurion® Vision System With Balanced Tip and the Infiniti® Vision System With the Mini Flared Kelman (MFK) Tip During Cataract Extraction Surgery of Hard Lenses
Cataracts
Primary: Cumulative Dissipated Energy (CDE) — 6.2; 11.4 percent-seconds — p=<.001
N/A N=200 Study of Phacodepth Required for Safe and Effective Chop During Phacoemulsification for Cataract.
Cataract
Primary: Phacodepth Required to Achieve Full Thickness Nuclear Crack — 2.5755 mm
N/A N=262 EYEFILL® C. -US Viscoelastic Clinical Investigation
Cataract
Primary: Mean Percent Cell Change (Preservation of Endothelium) — -10.05; -10.13 percent cell change
N/A N=100 Intra-Operative Metrics With CENTURION® and INFINITI® Vision Systems
Cataract
Primary: Cumulative Dissipated Energy — 4.32; 7.11 percent-seconds
N/A N=100 A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System
Cataract
Primary: Complete Capsulotomy — 98 participants
N/A N=102 The Cutting Efficiency of Hybrid Tips in Different Grades of Cataract
Cataract
Primary: Phaco Time — 41.6; 41.8 seconds
Phase 4 N=36 Co-Axial Micro-Incision Versus Co-Axial Small Incision Cataract Surgery Using the Stellaris Enhancement System
Cataract · Aphakia
Primary: Refractive Stability — 17; 23; 25; 25 Eyes
N/A N=36 Study to Evaluate the Safety of the Viscoelastic Substance PRO-149, Compared to Healon® EndoCoat.
Age-related Cataract · Phacoemulsification
Primary: Change in Corneal Endothelial Cell Count — -441.33; -482.3 cells/mm2
Phase 3 N=416 Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification
Intraocular Lens Replacement
Primary: Mean Area Under the Curve Analysis of Change-from-Baseline in Pupil Diameter (mm) During Surgery — 0.1; -0.5 mm — p=0.0001
N/A N=50 Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope
Cataract
Primary: Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope…
Phase 3 N=405 Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification
Intraocular Lens Replacement
Primary: Mean Area-under-the-Curve (AUC) Analysis of Change From Baseline in Pupil Diameter (mm) During Surgery — 0.1; -0.5 mm — p=<0.0001
Phase 4 N=30 Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
Diabetic Retinopathy · Macula Edema
Primary: Change in Central Retinal Thickness (CRT) — 384.62; 374; 349.15; 357.62 micrometer